In daily life, influenza might seem almost banal: how many of us get through the winter without a bout of flu? For those concerned with global health, however, few diseases provoke more unease. Influenza\'s history evokes the great themes of modern medicine: the insecure relationship between clinical knowledge and effective treatments; medicine\'s growing role in global networks of control; and the importance of memory and uncertainty in our responses to disease.

A 1999 WHO report noted that "on clinical grounds alone \[influenza\] cannot be distinguished from other acute respiratory infections", and these diagnostic difficulties compound the usual problems of tracing the history of a disease. Hippocrates, inevitably, is credited with the first description of influenza, although more compelling accounts have been found in European case records from the 12th century. "Influenza" seems to have come into English in the mid-18th century, from the Italian *influenza di freddo*, "the influence of the cold \[wind\]"---a turn of phrase reflecting classical views on environment and disease.

Influenza became modern in the summer of 1889, as an epidemic in Bukhara (now in Uzbekistan) turned into a pandemic of so-called Russian influenza. In an age of railways and steam trains, the disease spread swiftly, while industrial nations met it with a new kind of scientific medicine rooted in the laboratory, the microscope, and germ theory. Within a few years, most clinicians accepted that "Pfeiffer\'s bacillus"---a bacterium (*Haemophilus influenza*) identified by the German bacteriologist Richard Pfeiffer---was the cause of influenza.

In spring 1918, as Allied armies on the Western Front faced the last major German offensive, influenza began once more to spread around the world. The 1918--19 pandemic went on to infect perhaps a billion people in three waves, and killed at least 50 million. Societies already under immense wartime pressure faced near-collapse: hospitals and morgues were overwhelmed, transport and communications suffered staffing crises, and many governments closed schools, theatres, and churches. Their doctors, meanwhile, armed with Pfeiffer\'s work and newly confident in the power of germ theory, encountered a pandemic that was evidently infectious but that resisted all attempts at identification and treatment.
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As post-war governments struggled to reconstruct the international order, they put responses to influenza at the heart of the emerging paradigm of global health. The League of Nations Health Organization, the predecessor of WHO, was given the task of monitoring influenza outbreaks, and in the UK the new Ministry of Health initiated a search for the pathogen at the National Institute for Medical Research (NIMR). "Pfeiffer\'s bacillus" initially retained some support, but this dwindled after a team at the NIMR, led by the British physiologist Walter Morley Fletcher, linked influenza to a new class of pathogen---viruses---in 1933. The new discipline of immunology offered a way to distinguish different viral strains, by the haemagglutinin (H) and neuraminidase (N) antigens on the virus coat.

Influenza reappeared as a subject of international concern at the end of World War 2, with WHO co-ordinating a global network of research and surveillance from 1949. Subsequent pandemics---so-called Asian flu in 1957, Hong Kong flu in 1968, and the 1976 swine flu scare in the USA---highlighted the way in which new strains of influenza could emerge from natural reservoirs, notably pigs and wildfowl. HIV/AIDS provoked fresh interest in the largely forgotten 1918--19 pandemic, but the appearance of avian influenza and severe acute respiratory syndrome in the 1990s established a new cultural pattern for influenza outbreaks: travel restrictions, mass culls of pigs and chickens, intensive media interest, and worldwide anxiety.

In the early 21st century, influenza remains a substantial cause of mortality. New classes of antiviral drugs face the problem of rapid resistance, while antigenic shift and drift make the development of vaccines---the most effective response to influenza---a constant necessity. It is not clear whether even a coordinated global public health response would stop a new and more virulent pandemic. As we wait to find out, we might ask: what can medicine do to address the panic and uncertainty that characterise so many encounters with influenza?
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